Bal Pharma Profit & Loss Annual

Trade
BSE: 524824 | NSE: BALPHARMA | ISIN: INE083D01012 | Sector: Biotechnology & Drugs
133.20 -2.70 (-1.99%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 339.22304.22281.21250.53
Total Revenue 339.22304.22281.21250.53
Costof Revenue Total 191.75172.77167.53150.95
Gross Profit 147.47131.45113.6999.58
Selling/ General/ Admin Expenses Total 60.3855.3047.2541.88
Depreciation/ Amortization 10.079.139.049.52
Other Operating Expenses Total 55.5651.0342.9633.25
Total Operating Expense 317.76288.22266.78235.59
Operating Income 21.4615.9914.4414.94
Interest Inc( Exp) Net- Non- Op Total -152.58-100.57-85.08-105.39
Other Net 2.85-1.233.25-0.30
Net Income Before Taxes 9.054.759.184.10
Provisionfor Income Taxes 1.602.133.48-0.61
Net Income After Taxes 7.452.625.714.71
Minority Interest -0.05-0.05-0.090.03
Net Income Before Extra Items 7.392.575.614.74
Net Income 7.392.575.614.74
Total Adjustmentsto Net Income 0.00-0.00-
Income Availableto Com Excl Extra Ord 7.392.575.614.74
Income Availableto Com Incl Extra Ord 7.392.575.614.74
Diluted Net Income 7.392.575.614.74
Diluted Weighted Average Shares 1.581.571.511.42
Diluted EPS Excluding Extra Ord Items 4.681.643.713.34
DPS- Common Stock Primary Issue 1.201.001.001.00
Diluted Normalized EPS 4.681.633.713.34
Gain( Loss)on Saleof Assets -0.39--
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts